Safety of Tofacitinib in the Treatment of Rheumatoid Arthritis in Latin America Compared With the Rest of the World Population
Conclusion: This analysis of pooled data from clinical studies of tofacitinib in patients with RA demonstrates that tofacitinib has a consistent safety profile across LA and RoW patient populations.
Source: JCR: Journal of Clinical Rheumatology - Category: Rheumatology Tags: Original Articles Source Type: research
More News: Arthritis | Autoimmune Disease | Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Heart | Herpes | Lymphoma | Melanoma | Nonmelanoma Skin Cancer | Oral Cancer | Rheumatoid Arthritis | Rheumatology | Skin | Skin Cancer | Study | Tuberculosis